LORI FREEMAN: Open Payments
NPI 1912104043 · SAINT CHARLES, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 14 payments from 12 companies in 2025. Trend: 2023 $572 · 2024 $1,746 · 2025 $1,256
Food & beverage: $1,256
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $196 |
| Abbott Laboratories | 1 | $162 |
| Amgen Inc. | 1 | $129 |
| SANOFI PASTEUR INC. | 1 | $128 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| GENZYME CORPORATION | 2 | $110 |
| Tris Pharma Inc | 1 | $110 |
| AstraZeneca Pharmaceuticals LP | 1 | $98 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $86 |
| SANOFI-AVENTIS U.S. LLC | 1 | $61 |
Products named: Korlym, FREESTYLE LIBRE 3, BEYFORTUS, SHINGRIX, DUPIXENT, Dyanavel XR, BREZTRI, TZIELD.
Industry payments across MO — which companies pay providers there.
